UroGen Pharma Ltd. - COM (URGN)

Historical Portfolio Holders from Q2 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
138 K
Holdings value Q1 2024
$2.06 M
Value change Q1 2024
-$5.38 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
5
Number of buys Q1 2024
1
Number of sells Q1 2024
-14
Average buys Q1 2024 %
0%
Average sells Q1 2024 %
0%
CUSIP
M96088105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 138 K $2.06 M -$5.38 M $15.00 5
2023 Q4 20.9 M $314 M +$46.8 M $15.00 101
2023 Q3 17.7 M $248 M +$65.7 M $14.01 98
2023 Q2 13.2 M $137 M +$7.29 M $10.35 83
2023 Q1 12.3 M $114 M -$4.57 M $9.24 60
2022 Q4 13 M $115 M -$2.4 M $8.87 61
2022 Q3 13.3 M $110 M -$658 K $8.32 54
2022 Q2 13.1 M $107 M -$6.23 M $8.19 56
2022 Q1 14.2 M $124 M +$1.4 M $8.71 79
2021 Q4 14.5 M $137 M +$2.03 M $9.51 67
2021 Q3 14.1 M $237 M +$1.89 M $16.82 88
2021 Q2 12.1 M $184 M -$6.03 M $15.27 75
2021 Q1 14.3 M $278 M -$4.16 M $19.48 87
2020 Q4 14.5 M $261 M -$10.5 M $18.02 79
2020 Q3 15 M $288 M +$6.24 M $19.29 76
2020 Q2 14.7 M $382 M +$28.3 M $26.12 81
2020 Q1 13.3 M $237 M -$16.6 M $17.84 75
2019 Q4 14.2 M $472 M +$4.84 M $33.37 83
2019 Q3 14.6 M $347 M -$26.2 M $23.83 81
2019 Q2 14.7 M $527 M +$44.8 M $35.94 83
2019 Q1 13.5 M $497 M +$143 M $36.94 73
2018 Q4 9.15 M $394 M +$17.9 M $43.06 62
2018 Q3 9.92 M $468 M +$14.1 M $47.23 69
2018 Q2 9.6 M $482 M +$24.1 M $49.76 60
2018 Q1 9.14 M $454 M +$119 M $49.69 43
2017 Q4 6.84 M $254 M +$70 M $37.21 41
2017 Q3 4.6 M $144 M +$1.64 M $31.52 31
2017 Q2 4.72 M $85.2 M +$85.2 M $18.06 20